Science Explorer Back to mapMap
Discussion
Researcher · Aichi Cancer Center · Japan

Yoshitaka Sekido

Yoshitaka Sekido publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Occupational and environmental lung diseases, RNA modifications and cancer and Hippo pathway signaling and YAP/TAZ.

ORCID 0000-0002-2428-3848 OpenAlex
World rank
#65,873
of 7,710,434 ranked researchers
Rank in Japan
#360
of 383,136
Works
446
Citations
19k
Citations per work
43.5
h-index
78
i10-index 174Top 0.7% in Molecular Biology
Yoshitaka Sekido

What does Yoshitaka Sekido research?

Yoshitaka Sekido's work is mostly in Biochemistry, Genetics and Molecular Biology (45%), Medicine (32%).

Life Sciences: 202 works · 45.3% of their workBiochemistry, Genetics and Molecular Biology: 202 works · 45.3% of their workMolecular Biology: 149 works · 33.3% of their workCell Biology: 36 works · 8.0% of their workCancer Research: 18 works · 4.0% of their workHealth Sciences: 143 works · 32.0% of their workMedicine: 143 works · 32.0% of their workPulmonary and Respiratory Medicine: 83 works · 18.6% of their workOncology: 50 works · 11.3% of their workEpidemiology: 9 works · 2.1% of their workEverything else: 101 works · 22.7% of their workTHEIR WORKYoshitaka Sekido446works
Life Sciences45%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology20245.3%
    1. Medicine14332.0%
  3. Everything else10122.7%
  1. 1Molecular Biology33% of their works
  2. 2Pulmonary and Respiratory Medicine19% of their works
  3. 3Oncology11% of their works
  4. 4Cell Biology8% of their works
  5. 5Cancer Research4% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Yoshitaka Sekido's research?

The keywords of their largest research topics: Immunotherapy, Cancer, Cell Proliferation, BAP1 mutations, Malignant Pleural Mesothelioma, Regulation, Clinical Trials and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Immunotherapy702 topics
  2. Cancer572 topics
  3. Cell Proliferation572 topics
  4. BAP1 mutations551 topic
  5. Malignant Pleural Mesothelioma551 topic
  6. Regulation492 topics
  7. Clinical Trials442 topics
  8. Targeted Therapy442 topics
  9. RNA methylation401 topic
  10. m6A-seq401 topic
  11. Hippo Pathway331 topic
  12. YAP/TAZ331 topic
  13. ALK Inhibitors291 topic
  14. EGFR Mutations291 topic
  15. DNA Methylation281 topic
  16. Histone Modification281 topic
  17. Arginine Methylation241 topic
  18. Protein Arginine Methyltransferases241 topic
  19. Cell Cycle161 topic
  20. p53161 topic
  21. Genomic Profiles151 topic
  22. Small-Cell Lung Cancer151 topic

Where does Yoshitaka Sekido work?

Yoshitaka Sekido's main affiliation in the publication record is Aichi Cancer Center, Japan.

How many publications and citations does Yoshitaka Sekido have?

OpenAlex counts 446 works and 19,403 citations for Yoshitaka Sekido, an h-index of 78, ranking #65,873 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yoshitaka Sekido. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.